| UniProt ID | FXRD2_HUMAN | |
|---|---|---|
| UniProt AC | Q8IWF2 | |
| Protein Name | FAD-dependent oxidoreductase domain-containing protein 2 | |
| Gene Name | FOXRED2 {ECO:0000312|HGNC:HGNC:26264} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 684 | |
| Subcellular Localization | Endoplasmic reticulum lumen . | |
| Protein Description | Probable flavoprotein which may function in endoplasmic reticulum associated degradation (ERAD). May bind non-native proteins in the endoplasmic reticulum and target them to the ubiquitination machinery for subsequent degradation.. | |
| Protein Sequence | MGLSAAAPLWGPPGLLLAIALHPALSVPPRRDYCVLGAGPAGLQMAYFLQRAGRDYAVFERAPRPGSFFTRYPRHRKLISINKRYTGKANAEFNLRHDWNSLLSHDPRLLFRHYSRAYFPDARDMVRYLGDFADTLGLRVQYNTTIAHVTLDKDRQAWNGHYFILTDQKGQVHQCSVLFVATGLSVPNQVDFPGSEYAEGYESVSVDPEDFVGQNVLILGRGNSAFETAENILGVTNFIHMLSRSRVRLSWATHYVGDLRAINNGLLDTYQLKSLDGLLESDLTDLAILKDSKGKFHVTPKFFLEEANTNQSADSITLPQDDNDNFAMRVPYDRVIRCLGWNFDFSIFNKSLRLNSGNAFGKKYPLIRASYESKGSRGLFILGTASHSVDYRKSAGGFIHGFRYTVRAVHRLLEHRHHSVTWPATELPITQLTSSIVRRVNEASGLYQMFGVLADVILLKENSTAFEYLEEFPIQMLAQLETLTGRKAKHGLFVINMEYGRNFSGPDKDVFFDDRSVGHTEDAWQSNFLHPVIYYYRYLPTEQEVRFRPAHWPLPRPTAIHHIVEDFLTDWTAPIGHILPLRRFLENCLDTDLRSFYAESCFLFALTRQKLPPFCQQGYLRMQGLVSTESLWQHRVESRLLRDYAPTGRRLEDSSQQLGDQEPLGSPLAPGPLAQSVDSNKEEL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 33 | Phosphorylation | SVPPRRDYCVLGAGP CCCCCCCCEEECCCH | 5.22 | 18083107 | |
| 47 | Phosphorylation | PAGLQMAYFLQRAGR HHHHHHHHHHHHCCC | 10.24 | 18083107 | |
| 77 | Ubiquitination | TRYPRHRKLISINKR CCCCCCCCEEEECCC | 44.01 | - | |
| 83 | Ubiquitination | RKLISINKRYTGKAN CCEEEECCCCCCCCC | 45.15 | 22817900 | |
| 88 | Ubiquitination | INKRYTGKANAEFNL ECCCCCCCCCCEEEC | 30.57 | 21963094 | |
| 101 | Phosphorylation | NLRHDWNSLLSHDPR ECCCCHHHHHCCCHH | 26.83 | 29449344 | |
| 104 | Phosphorylation | HDWNSLLSHDPRLLF CCHHHHHCCCHHHHH | 31.01 | 29449344 | |
| 114 | Phosphorylation | PRLLFRHYSRAYFPD HHHHHHHHHHHHCCC | 8.80 | 28270605 | |
| 115 | Phosphorylation | RLLFRHYSRAYFPDA HHHHHHHHHHHCCCH | 12.33 | 28270605 | |
| 118 | Phosphorylation | FRHYSRAYFPDARDM HHHHHHHHCCCHHHH | 17.97 | 24719451 | |
| 143 | N-linked_Glycosylation | LGLRVQYNTTIAHVT HCCEEEECCEEEEEE | 17.41 | 19159218 | |
| 153 | Ubiquitination | IAHVTLDKDRQAWNG EEEEEECCCCCHHCC | 58.90 | - | |
| 181 (in isoform 2) | Ubiquitination | - | 6.66 | 21906983 | |
| 253 | Phosphorylation | RVRLSWATHYVGDLR CCCHHHHHHHHHHHH | 13.89 | 27251275 | |
| 255 | Phosphorylation | RLSWATHYVGDLRAI CHHHHHHHHHHHHHH | 11.19 | 27251275 | |
| 269 | Phosphorylation | INNGLLDTYQLKSLD HHCCCCCEEECCCCC | 17.09 | 27251275 | |
| 270 | Phosphorylation | NNGLLDTYQLKSLDG HCCCCCEEECCCCCC | 16.12 | 27251275 | |
| 272 | Ubiquitination | GLLDTYQLKSLDGLL CCCCEEECCCCCCHH | 2.61 | 21963094 | |
| 273 | Ubiquitination | LLDTYQLKSLDGLLE CCCEEECCCCCCHHH | 33.19 | 22817900 | |
| 290 | Ubiquitination | LTDLAILKDSKGKFH CCHHHHEECCCCCEE | 54.57 | 21963094 | |
| 293 | Ubiquitination | LAILKDSKGKFHVTP HHHEECCCCCEEECC | 76.02 | 22817900 | |
| 295 | Ubiquitination | ILKDSKGKFHVTPKF HEECCCCCEEECCHH | 35.71 | 22817900 | |
| 350 | Ubiquitination | FDFSIFNKSLRLNSG CCEEEECCHHCCCCC | 39.87 | 21963094 | |
| 356 | Phosphorylation | NKSLRLNSGNAFGKK CCHHCCCCCCCCCCC | 37.71 | 24732914 | |
| 362 | Ubiquitination | NSGNAFGKKYPLIRA CCCCCCCCCCCEEEE | 42.55 | 21963094 | |
| 363 | Ubiquitination | SGNAFGKKYPLIRAS CCCCCCCCCCEEEEE | 53.10 | 22817900 | |
| 374 | Ubiquitination | IRASYESKGSRGLFI EEEEEECCCCCEEEE | 49.30 | - | |
| 393 | Ubiquitination | SHSVDYRKSAGGFIH ECCCEEHHHCCCCCC | 38.13 | - | |
| 508 | Ubiquitination | RNFSGPDKDVFFDDR CCCCCCCCCCCCCCC | 59.95 | 21906983 | |
| 508 (in isoform 1) | Ubiquitination | - | 59.95 | 21906983 | |
| 610 | Ubiquitination | LFALTRQKLPPFCQQ HHHHHHCCCCHHHHH | 60.72 | - | |
| 666 | O-linked_Glycosylation | GDQEPLGSPLAPGPL CCCCCCCCCCCCCCC | 25.15 | OGP |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of FXRD2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FXRD2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FXRD2_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-143, AND MASSSPECTROMETRY. | |